On this page
Ezetimibe
Active ingredient 5 prescription 5 with labelling
Overview
Source: NDC DirectoryIngredient name
EZETIMIBE
Base moiety
EZETIMIBE
RxNorm CUI
UNII
EOR26LQQ24
Medication products
9
Brand names
5
Dosage forms
4
FAERS reports
262,992 · not a risk measure
- bempedoic acid and ezetimibe Tablet, Film Coated
- Ezetimibe Powder
- Ezetimibe Granule
- Ezetimibe (Form-B) Powder
- Nexlizet Bempedoic Acid and Ezetimibe · Tablet, Film Coated
- Zetia Ezetimibe · Tablet
- Ezetimibe Tablet
- Ezetimibe and Simvastatin Tablet
- VYTORIN ezetimibe and simvastatin · Tablet
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Tablet | 4 | Zetia, Ezetimibe, Ezetimibe and Simvastatin, VYTORIN |
| TABLET, Film Coated | 2 | bempedoic acid and ezetimibe, Nexlizet |
| Powder | 2 | Ezetimibe, Ezetimibe (Form-B) |
| Granule | 1 | Ezetimibe |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |